Universe Pharmaceuticals (UPC) Notes Payables (2021 - 2025)
Universe Pharmaceuticals (UPC) has disclosed Notes Payables for 5 consecutive years, with $7.1 billion as the latest value for Q3 2025.
- Quarterly Notes Payables rose 22.08% to $7.1 billion in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $7.1 billion through Sep 2025, up 22.08% year-over-year, with the annual reading at $7.1 billion for FY2025, 22.08% up from the prior year.
- Notes Payables hit $7.1 billion in Q3 2025 for Universe Pharmaceuticals, up from $5.9 billion in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $7.1 billion in Q3 2025 to a low of $3.9 million in Q3 2022.
- Historically, Notes Payables has averaged $2.6 billion across 5 years, with a median of $5.5 million in 2023.
- Biggest five-year swings in Notes Payables: fell 9.19% in 2022 and later skyrocketed 106726.27% in 2024.
- Year by year, Notes Payables stood at $4.3 million in 2021, then decreased by 9.19% to $3.9 million in 2022, then skyrocketed by 39.28% to $5.5 million in 2023, then surged by 106726.27% to $5.9 billion in 2024, then rose by 22.08% to $7.1 billion in 2025.
- Business Quant data shows Notes Payables for UPC at $7.1 billion in Q3 2025, $5.9 billion in Q3 2024, and $5.5 million in Q3 2023.